Monitor measures early signs of pulmonary oedema:
This article was originally published in Clinica
Israeli company RS Medical Monitoring has developed a device to monitor patients for early signs of pulmonary oedema, a potentially fatal complication associated with acute heart disease. The monitor, which measures changes in the active resistance in the lungs caused by an accumulation of fluids, gives an audio-visual signal if the fluid level exceeds or falls below pre-set levels.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.